Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?

被引:770
作者
Dejager, Lien [1 ,2 ]
Pinheiro, Iris [1 ,2 ]
Dejonckheere, Eline [1 ,2 ]
Libert, Claude [1 ,2 ]
机构
[1] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium
[2] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium
关键词
ACTIVATED PROTEIN-C; IMPROVES SURVIVAL; SEPTIC SHOCK; INNATE IMMUNITY; MONOCLONAL-ANTIBODY; REGULATES SEPSIS; INTERFERON-GAMMA; HOST-DEFENSE; PERITONITIS; MICE;
D O I
10.1016/j.tim.2011.01.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Sepsis is a serious medical condition characterized by dysregulated systemic inflammatory responses followed by immunosuppression. To study the pathophysiology of sepsis, diverse animal models have been developed. Polymicrobial sepsis induced by cecal ligation and puncture (CLP) is the most frequently used model because it closely resembles the progression and characteristics of human sepsis. Here we summarize the role of several immune components in the pathogenesis of sepsis induced by CLP. However, several therapies proposed on the basis of promising results obtained by CLP could not be translated to the clinic. This demonstrates that experimental sepsis models do not completely mimic human sepsis. We propose several strategies to narrow the gap between experimental sepsis models and clinical sepsis, including targeting factors that contribute to the immunosuppressive phase of sepsis, and reproducing the heterogeneity of human patients.
引用
收藏
页码:198 / 208
页数:11
相关论文
共 100 条
[1]
Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis [J].
Alves, JC ;
de Freitas, A ;
Russo, M ;
Cunha, FQ .
CRITICAL CARE MEDICINE, 2006, 34 (02) :461-470
[2]
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[3]
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis [J].
Annane, D ;
Bellissant, E ;
Bollaert, PE ;
Briegel, J ;
Keh, D ;
Kupfer, Y .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7464) :480-484
[4]
Immune depression in polymicrobial sepsis: The role of necrotic (injured) tissue and endotoxin [J].
Ayala, A ;
Song, GY ;
Chung, CS ;
Redmond, KM ;
Chaudry, IH .
CRITICAL CARE MEDICINE, 2000, 28 (08) :2949-2955
[5]
BAKER CC, 1983, SURGERY, V94, P331
[6]
Molecular diagnostics of sepsis - Where are we today? [J].
Bauer, Michael ;
Reinhart, Konrad .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 300 (06) :411-413
[7]
Septic mice are susceptible to pulmonary aspergillosis [J].
Benjamim, CF ;
Hogaboam, CM ;
Lukacs, NW ;
Kunkel, SL .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (06) :2605-2617
[8]
Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[9]
Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis [J].
Bopp, Christian ;
Bierhaus, Angelika ;
Hofer, Stefan ;
Bouchon, Axel ;
Nawroth, Peter P. ;
Martin, Eike ;
Weigand, Markus A. .
CRITICAL CARE, 2008, 12 (01)
[10]
Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis [J].
Brahmamdam, Pavan ;
Inoue, Shigeaki ;
Unsinger, Jacqueline ;
Chang, Katherine C. ;
McDunn, Jonathan E. ;
Hotchkiss, Richard S. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 88 (02) :233-240